Doctor's Bio
Dr. Lauren Collins is an Assistant Professor of Medicine in the Division of Infectious Diseases at Emory University. She received a BS in Microbiology and a minor in Spanish language from the University of Georgia. She is a graduate of the Boston University School of Medicine and completed her Internal Medicine residency at Duke University. She completed her Infectious Diseases fellowship and Master of Science in Clinical Research at Emory University.
Dr. Collins’ clinical and research interests focus on improving the care of persons with HIV and in particular, women with HIV and those affected by the Southern HIV/AIDS epidemic. In her research, she studies the mounting burden of aging-related comorbidities experienced by persons with HIV and specifically investigates the role of sex differences as well as traditional versus HIV-specific risk factors contributing to overall comorbidity burden. Her research objective is to develop novel, cost-effective comorbidity screening and prevention tools and strategies for persons with HIV. She is also interested in the clinical, service delivery and public health implications of coinfections affecting persons with HIV, including chronic HCV and SARS-CoV-2.
Most recently, she co-led the implementation of a pilot program using long-acting injectable antiretroviral therapy for HIV treatment at the Grady IDP Center. She is a KL2 career development awardee supported by the Georgia Clinical and Translational Science Alliance and is also a co-investigator of the NIH-funded MACS/WIHS Combined Cohort Study (MWCCS) and the Emory Specialized Center of Research Excellence on Sex Differences (SCORE).
Board Certifications
American Board of Internal Medicine
Affiliations
Emory
Education & Training
- Medical School: Boston University School of Medicine
- Residency: Duke University Medical Center
Fellowships
Emory University Hospital
Locations and Directions
Ponce De Leon Center
Phone: (404) 616-2440
Location:
341 Ponce De Leon Ave. NE
Atlanta, GA 30308
Publications
- Long-acting cabotegravir/rilpivirine, lenacapavir, and ibalizumab use among persons with HIV-1 viremia at a Ryan White-funded clinic in the urban U.S. South.
Colasanti JA, Aldredge A, Niles-Carnes LV, Ochieng E, Pareek P, Robinson V, Anderson E, Castaneda M, Spralling H, Smith BL, Sumitani J, Paul Leue E, Moran CA, Lora M, Armstrong WS, Collins LF
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2025;
PMID: 40747944 - Promoting Healthy Aging in People With HIV-Into a New Era.
Collins LF, Cunningham SA, Vaughan CP, Ofotokun I
JAMA. 2025;334(5):387-388.
PMID: 40601328 - A Guide to the Evolving Clinical Landscape of Low-Level Viremia Among Persons with HIV in the Modern Treatment Era.
Aldredge A, Patel C, Sheth AN, Collins LF
Current HIV/AIDS reports. 2025;22(1):39.
PMID: 40569488 - Comparing interest in thigh administration of long-acting cabotegravir/rilpivirine among hypothetical users, early adopters and trial participants with experience.
Collins LF, Christopoulos KA, McNulty MC, Colasanti JA
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2025;
PMID: 40560533 - Hepatic Markers and Immunological Trajectories in a Cohort of Patients with HIV and Hepatitis C Virus Coinfection Treated with Direct-Acting Antivirals.
Simoncini G, Li J, Mayer C, Collins LF, Battalora L, Buchacz K,
AIDS research and human retroviruses. 2025;41(8):400-410.
PMID: 40397618 - Comparative genomic analysis of emerging non-typeable (NTHi) causing emerging septic arthritis in Atlanta.
Bixler BJ, Royer CJ, Petit Iii RA, Moller AG, Sefton S, Thomas S, Tunali A, Collins LF, Farley MM, Satola SW, Read TD
PeerJ. 2025;
PMID: 40130174 - Enhancing Hepatitis B Virus Vaccine Uptake and Immunity Through Long-Acting Antiretroviral Therapy Programmatic Synergy in the US South.
Ochieng E, Robinson V, Anderson E, Niles-Carnes L, Smith BL, Armstrong WS, Lora M, Colasanti JA, Collins LF
Open forum infectious diseases. 2025;12(3):ofaf096.
PMID: 40046888 - Early Implementation of Long-Acting Injectable Cabotegravir for HIV Prevention in a Safety Net Hospital-based Primary Care Center in U.S. South.
Baker D, Collins LF, Cantos VD, Hollenberg E, Kaplan A, Cowan T, Garcia J, Lora M
Journal of general internal medicine. 2025;
PMID: 39934566 - Policy Recommendations to Support Equitable Access to Long-Acting Injectables for Human Immunodeficiency Virus Prevention and Treatment: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association.
Marcus JL, Weddle A, Kelley CF, Agwu A, Montalvo S, Sherman E, Vijayan T, Gutierrez J, Hickey MD, Dilworth SE, Krakower D, Davis TL, Collins LF, McNulty MC, Colasanti JA, Christopoulos KA
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2025;
PMID: 39873495 - Heterogeneous depressive symptom trajectories among women with type 2 diabetes: findings from the Women's Interagency HIV Study.
Perez NB, D'Eramo Melkus G, Fletcher J, Allen-Watts K, Jones DL, Collins LF, Ramirez C, Long A, Cohen MH, Merenstein D, Wilson TE, Sharma A, Aouizerat B
Annals of behavioral medicine : a publication of the Society of Behavioral Medicine. 2025;
PMID: 39671516
PLANNING
PREPARING FOR YOUR VISIT
Whether you’re a patient or you’re visiting one, a little planning beforehand can make your visit to Grady easier and more comfortable. Here, you’ll find everything you need to prepare for your visit, including an appointment checklist, admissions information, dining options, and much more.